Medication info
Glivec (Memantine Hydrochloride)

Glivec (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Pale yellow to yellow oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201603359 · Approved 2016.06.10 · Insurance code 694001310

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment should be initiated only by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only when a caregiver is available to regularly check that the patient is taking the medicine. Diagnosis should be made in accordance with currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed regularly. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Older adults: Based on clinical data, the recommended dose for patients 65 years of age and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to such patients.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. Alzheimer's disease is a neurodegenerative disorder characterized by a gradual decline in memory and cognitive function, and this drug helps alleviate these symptoms and improve the quality of life for patients.

How to take

Adult dose

Treatment should be initiated only by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only when a caregiver is available to regularly check that the patient is taking the medicine. Diagnosis should be made in accordance with currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed regularly. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Older adults: Based on clinical data, the recommended dose for patients 65 years of age and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine to such patients.

Precautions

This medication should not be used in patients who are allergic to any component of this medicine. It should not be administered to patients with very poor liver function or severely impaired kidney function. Use with caution in patients with a history of seizures or epilepsy, as there is a potential for increased side effects when taken with certain medications. Particular caution is needed in patients who may experience changes in urine acidity or have recently had heart problems. Side effects such as dizziness, headaches, constipation, drowsiness, and elevated blood pressure may occur during treatment; if symptoms are severe, consult a doctor. As there may be interactions with other medications, especially specific CNS medications, antihypertensives, and anticoagulants, always inform healthcare professionals if taking any of these. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits of using this medication, and it is recommended to discontinue breastfeeding if nursing. It is advisable to avoid use in children and adolescents under 18 years of age as safety and efficacy have not been established. In case of overdose, central nervous system symptoms or digestive symptoms may occur, so seek medical attention immediately for appropriate treatment. This medication may slow the response time, so caution is required when driving or operating machinery. Store the medicine out of reach of children and do not transfer it to a different container.

Side effects

  • dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychiatric reaction
Show 24 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thrombosis/thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • agitation
  • aggression
  • delirium
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius to safely preserve its effectiveness.

Appearance and packaging

Appearance

Pale yellow to yellow oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.